Assignee
EHLBIO CO LTD
KR·0 granted patents·2 pending applications·0 citations·filing 2022–2022
Top patents by PatentIndex Score
2 records- 0160US2025195578A1Medium composition for culturing urine-derived stem cell, method for isolating and culturing urine-derived stem cell using same, urine-derived stem cell with improved therapeutic function for renal disease, and cell therapy product composition containing sameEHLBIO CO LTD·Filed 2022·Application pending·0 cites
- 0258US2024216435A1Composition for skin regeneration, whitening, antioxidation, or wound treatment, comprising stem cell-derived exosome as active ingredient, and use thereofEHLBIO CO LTD·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when EHLBIO CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →